back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-04-01 15:43 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+587,000 vol |
1,037,000 | |
| Filed 2019-04-15 14:00 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,000
+150,000 vol $1.28 each |
450,000 | |
| Filed 2018-07-04 Tx date 2018-06-01 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2015-10-09 Tx date 2015-10-07 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$840,000
+2,000,000 vol $0.42 each |
2,000,000 | |
| Filed 2015-10-09 Tx date 2015-10-01 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-09 Tx date 2015-10-01 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$800,000
+2,000,000 vol $0.40 each |